Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Vivo Capital IX, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.
Txns: Bought 3,157,894 shares @ $1.9, valued at $6M
Bought 3,157,894 warrants @ $2.47, valued at $7.8M
07/05/2022 SC 13G/A Vivo Capital IX, LLC reports a 0% stake in Sierra Oncology, Inc.
07/01/2022 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Disposed/sold 161,712 shares @ $55, valued at $8.9M
Disposed/sold 2,735,853 shares @ $55, valued at $150.5M
Disposed/sold 431,947 shares @ $55, valued at $23.8M
Disposed/sold 324,740 options to buy @ $13.2, valued at $4.3M
Disposed/sold 1,455,384 options to buy @ $13.2, valued at $19.2M
Disposed/sold 75,749 options to buy @ $13.2, valued at $999.9k
05/04/2022 4 Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 41,800 shares @ $15.19, valued at $634.9k
Sold 451,418 shares @ $13.25, valued at $6M
Sold 19,738 shares @ $12.67, valued at $250.1k
02/11/2022 SC 13G/A Vivo Capital IX, LLC reports a 1.8% stake in Larimar Therapeutics, Inc.
02/11/2022 SC 13G/A Vivo Capital IX, LLC reports a 7.8% stake in Mereo BioPharma Group plc
02/11/2022 SC 13G/A Vivo Capital IX, LLC reports a 4.5% stake in IVERIC bio, Inc.
02/11/2022 SC 13G/A Vivo Capital IX, LLC reports a 1.4% stake in ESSA Pharma Inc.
02/11/2022 SC 13G/A Vivo Capital IX, LLC reports a 14.7% stake in Sierra Oncology, Inc.
02/11/2022 SC 13G/A Vivo Capital IX, LLC reports a 14.4% stake in Tarsus Pharmaceuticals, Inc.
01/31/2022 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Bought 800,000 shares @ $27, valued at $21.6M
01/28/2022 4 Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Exercised (in-or-at-the-money) 75,749 options to buy @ $13.2, valued at $999.9k
Exercised (in-or-at-the-money) 1,455,384 options to buy @ $13.2, valued at $19.2M
Exercised (in-or-at-the-money) 324,740 options to buy @ $13.2, valued at $4.3M
11/12/2021 SC 13G Vivo Capital IX, LLC reports a 10.5% stake in IO Biotech, Inc.
11/12/2021 4 Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.
Txns: Converted 2,365,545 shares @ $0
Bought 650,000 shares @ $14, valued at $9.1M
Converted 188,168 preferred shares @ $0
11/05/2021 SC 13G/A Vivo Capital IX, LLC reports a 14.8% stake in Sierra Oncology, Inc.
11/04/2021 3 Vivo Capital IX, LLC (10% Owner) has filed a Form 3 on IO Biotech, Inc.
07/23/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2021 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
03/18/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/06/2020 SC 13G Vivo Capital IX, LLC reports a 4.4% stake in ESSA Pharma Inc.
10/28/2020 SC 13G Vivo Capital IX, LLC reports a 16.2% stake in Tarsus Pharmaceuticals, Inc.
10/20/2020 4 Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Converted 2,780,754 shares @ $0
Converted 214,281 shares @ $0
Bought 250,000 shares @ $16, valued at $4M
Converted 2,780,754 preferred shares @ $0
Converted 214,281 preferred shares @ $0
10/15/2020 3 Vivo Capital IX, LLC (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc.
07/29/2020 SC 13G Vivo Capital IX, LLC reports a 11.1% stake in ALX Oncology Holdings Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy